Abstract:Advancements in recombinant DNA technology have made proteins and peptides available for diagnostic and therapeutic applications, but their effectiveness when taken orally leads to poor patient compliance, requiring clinical administration. Among the alternative routes, transmucosal delivery has the advantage of being noninvasive and bypassing hepato-gastrointestinal clearance. Various mucosal routes—buccal, nasal, pulmonary, rectal, and vaginal—have been explored for delivering these macromolecules. Nanofibers, due to their unique properties like high surface-area-to-volume ratio, mechanical strength, and improved encapsulation efficiency, serve as promising carriers for proteins and peptides. These nanofibers can be tailored for quick dissolution, controlled release, enhanced encapsulation, targeted delivery, and improved bioavailability, offering superior pharmaceutical and pharmacokinetic performance compared to conventional methods. This leads to reduced dosages, fewer side effects, and enhanced patient compliance. Hence, nanofibers hold tremendous potential for protein/peptide delivery, especially through mucosal routes. This review focuses on the therapeutic application of proteins and peptides, challenges faced in their conventional delivery, techniques for fabricating different types of nanofibers and, various nanofiber-based dosage forms, and factors influencing nanofiber generation. Insights pertaining to the precise selection of materials used for fabricating nanofibers and regulatory aspects have been covered. Case studies wherein the use of specific protein/peptide-loaded nanofibers and delivered via oral/vaginal/nasal mucosa for diagnostic/therapeutic use and related preclinical and clinical studies conducted have been included in this review. Graphical

Advances of nanoparticles in transmucosal drug delivery

Nanoparticles in the Ocular Drug Delivery

Advances in the Transport of Oral Nanoparticles in Gastrointestinal Tract

Nanoparticle-Mediated Strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa

Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines

Recent Advances in Drug Delivery Systems for Enhancing Drug Penetration into Tumors

Progress in the Application of Nano- and Micro-based Drug Delivery Systems in Pulmonary Drug Delivery

Polymeric nanoparticle drug delivery technologies for oral delivery applications

Nanoparticles-encapsulated Polymeric Microneedles for Transdermal Drug Delivery

Research Progress on the Mechanism of Nanoparticles Crossing the Intestinal Epithelial Cell Membrane

Recent Progress in Transdermal Nanocarriers and Their Surface Modifications

Traditional Chinese medicine polysaccharide in nano-drug delivery systems: Current progress and future perspectives

Recent Advancements in Nanopharmaceuticals for Novel Drug Delivery Systems

Strategies to improve tumor penetration of nanomedicines through nanoparticle design

Nanoparticle oral absorption and its clinical translational potential

Transepithelial transport of nanoparticles in oral drug delivery: From the perspective of surface and holistic property modulation

Advances of nanoparticles as drug delivery systems for disease diagnosis and treatment

Advanced Application of Polymer Nanocarriers in Delivery of Active Ingredients from Traditional Chinese Medicines

Beyond Nanoparticle-based Oral Drug Delivery: Transporter-mediated Absorption and Disease Targeting

Transmucosal Delivery of Peptides and Proteins Through Nanofibers: Current Status and Emerging Developments

Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs